Atovaquon Glenmark

Atovaquone is an antimalarial medication used to treat and prevent malaria. This oral medication is manufactured by Glenmark Arzneimittel Gmbh and is available in various strengths.

Atovaquone is primarily used to treat and prevent malaria, a disease caused by parasites transmitted through mosquito bites. It works by interfering with the growth of the parasites in the red blood cells. Atovaquone is also sometimes used for other parasitic infections as determined by a healthcare provider.

Common effects of Atovaquone may include nausea, vomiting, diarrhea, and headache. Some users may also experience dizziness, fever, or cough. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare professional.

Atovaquone should be used with caution in individuals with severe liver or kidney disease. It is important to follow the prescribed dosage and complete the full course of treatment to ensure effectiveness. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Atovaquone may interact with certain medications, including antacids, metoclopramide, and drugs that affect liver enzymes. It is advisable to avoid alcohol while taking Atovaquone, as it may increase the risk of side effects. Always consult a healthcare provider before starting any new medication.